PCSK9 and posterior cortical atrophy: Genetically proxied proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition may involve biological mechanisms that reduce the risk of overall and early-onset PCa through the regulation of Lp (a) (104, 105).